(Q48754272)

15 February 2018

title

Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat. (English)

1 reference

15 February 2018

author name string

King CM

1

1 reference

15 February 2018

Gommans J

2

1 reference

15 February 2018

Joordens RJ

3

1 reference

15 February 2018

Hijzen TH

4

1 reference

15 February 2018

Maes RA

5

1 reference

15 February 2018

Olivier B

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

15 February 2018

European Journal of Pharmacology

published in

1 reference

15 February 2018

volume

325

1 reference

15 February 2018

page(s)

121-128

1 reference

15 February 2018

issue

2-3

1 reference

15 February 2018

Pilot study of flesinoxan, a 5-HT1A agonist, in major depression: Effects on sleep REM latency and body temperature

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Anticonflict effects of the 5-HT1A compound flesinoxan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Presynaptic 5-HT1A receptors mediate the effect of ipsapirone on punished responding in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

5-HT1A receptor agonists: recent developments and controversial issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

An open study of oral flesinoxan, a 5-HT1A receptor agonist, in treatment-resistant depression

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Fear-potentiated startle response is remarkably similar in two laboratories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment with para-chlorophenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

New animal models of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Effects of drugs on punished behavior: pre-clinical test for anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Pharmacological and clinical effects of buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Discriminative stimulus properties of flesinoxan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Behavioral effects of several new anxiolytics and putative anxiolytics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

Stress-induced hyperthermia as a putative anxiety model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900114-3

10.1016/S0014-2999(97)00114-3

7 January 2021

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9163558

1 reference

15 February 2018